ArticleJournal of the National Cancer Institute2023

Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials.

Patricia M LoRusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.